Millennium Management
ERNA icon

Millennium Management’s Eterna Therapeutics ERNA Stock Holding History

Millennium Management’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-120
Closed -$13.2K – 5997
2024
Q4 		$13.2K Buy
+120
New +$32.5K ﹤0.01% 5760
2022
Q4 		– Sell
-112
Closed -$207K – 6678
2022
Q3 		$207K Buy
112
+68
+155% +$234K ﹤0.01% 5639
2022
Q2 		$170K Buy
+44
New +$316K ﹤0.01% 5712
2022
Q1 		– Sell
-3
Closed -$85K – 7043
2021
Q4 		$85K Hold
3
– – ﹤0.01% 6315
2021
Q3 		$187K Sell
3
-2
-40% -$173K ﹤0.01% 6150
2021
Q2 		$718K Buy
+5
New +$720K ﹤0.01% 4968

Other funds holding ERNA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
SCA
Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Millennium Management's ERNA Position: Q1 2025 in Review

Millennium Management sold out of Eterna Therapeutics (ERNA) in Q1 2025, closing a stake of 120 shares — an estimated $13.2K sold.

Millennium Management first reported a position in ERNA in Q2 2021 and held it in 6 quarters. The position peaked at $718K in Q2 2021. 20 funds tracked by Wall St. Rank hold ERNA as of Q1 2025.

  • Millennium Management reported no remaining Eterna Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 120 Eterna Therapeutics shares in Q1 2025, an estimated $13.2K.
  • Millennium Management first reported a position in Eterna Therapeutics in Q2 2021 and held it in 6 quarters.
  • Millennium Management's Eterna Therapeutics position peaked at $718K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.